FDA
-
-
-
-
-
-
-
ZETA SURGICAL® Announces Successful Treatment of First Patient with Zeta TMS Navigation System at HOPE Therapeutics
-
-
-
-
-
-
-
NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2026 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
NRx Pharmaceuticals receives FDA feedback on ketamine drug application
-
-
-
-
-
-
-
BTIG stays Buy rated on NRx Pharmaceuticals, Inc. (NRXP) as FDA waives additional clinical trials
-
-
-
-
-
-
-
NRx Pharmaceuticals, Inc. (NRXP) PT Raised to $45 at H.C. Wainwright
-
-
-
-
-
-
-
NRx Pharmaceuticals to submit 70,000 patient ketamine data to FDA
-
-
-
-
-
-
-
HOPE Therapeutics launches one-day depression treatment in Florida
-
325,300 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

